This policy does not certify benefits or authorization of benefits, which is designated by each individual policyholder contract. Paramount applies coding edits to all medical claims through coding logic software to evaluate the accuracy and adherence to accepted national standards. This guideline is solely for explaining correct procedure reporting and does not imply coverage and reimbursement.
Therapeutic soft hydrophilic contact lenses (TSCLs) are disposable plastic lenses made of polymer material that are hydrophilic to absorb or attract a certain volume of water and which cover the entire cornea. These soft lenses are worn directly against the cornea and are prescribed for the treatment of acute or chronic corneal pathology such as persistent epithelial defects (PEDs). Many types of soft tissue lenses are available for therapeutic use (e.g., Focus® Night & Day® Lens).
Gas impermeable scleral contact lenses (scleral shell or shield) is a catchall term for different types of hard scleral contact lenses. A scleral shell fits over the entire exposed surface of the eye as opposed to a corneal contact lens which covers only the central non-white area encompassing the pupil and iris. Where an eye has been rendered sightless and shrunken by inflammatory disease, a scleral shell may, among other things, obviate the need for surgical enucleation and prosthetic implant.
Scleral lenses may be used to improve vision and reduce pain and light sensitivity for people suffering from growing number of disorders or injuries to the eye, such as Microphthalmia, corneal ectasia, Stevens-Johnson syndrome, Sjögren's syndrome, aniridia, neurotrophic keratitis (anesthetic corneas), complications post-LASIK, complications post-corneal transplant and pellucid degeneration. Injuries to the eye such as surgical complications, distorted corneal implants, as well as chemical and burn injuries also may be treated by the use of scleral lenses.
Rigid gas permeable scleral contact lenses, which are also known as ocular surface prostheses, are formed with an elevated chamber over the cornea and a haptic base over the sclera. Scleral contact lenses are being evaluated in patients with corneal disease, including keratoconus, Stevens-Johnson syndrome, chronic ocular graft-versushost disease, and in patients with reduced visual acuity after penetrating keratoplasty or other types of eye surgery.
The Boston Scleral Lens is a fluid-filled, ventilated, gas permeable contact lens made from Equalens II®, a type of plastic that allows oxygen to pass through easily. This lens is currently being used for patients with severe ocular surface disease and patients who have irregular astigmatism, in which the curvature of the cornea is uneven or bumpy. Unlike conventional contact lenses, scleral lenses rest completely on the sclera, the outer white portion of the surface of the eye, to create a fluid-filled space or reservoir over the diseased and/or irregular cornea. This smooth liquid overlay fills in bumps on the corneal surface to improve vision. The fluid reservoir also acts as a liquid bandage that protects the cornea from exposure to air and the friction of blinking, to reduce eye pain and oversensitivity to light. Healing of corneal damage seems to be aided by a combination of oxygenation, moisture, and protection of the fragile layer of cells on the surface of the cornea.
POLICY
Therapeutic soft hydrophilic contact lenses (V2520, V2521, V2522, V2523), and gas impermeable scleral contact lenses (scleral shell or shield) (V2530) require prior authorization for all product lines.
Rigid gas permeable scleral lens (S0515, V2531) requires prior authorization for HMO, PPO, Individual Prior authorization can be given only if at least one of the following criteria is met:
 The lens or lenses will be used to correct aphakia  The lens or lenses will be used to correct high refractive errors, greater than ten diopters, the visual acuity cannot be corrected to 20/70 in the better eye with spectacles, and there is significant improvement in visual acuity with contact lenses  There is a high degree of anisometropia, and binocularity can be substantiated  The lens or lenses will be used to treat keratoconus, there is a high degree of corneal astigmatism or corneal irregularity, the visual acuity cannot be corrected to 20/70 in the better eye with spectacles, and there is a significant improvement with contact lenses Therapeutic soft hydrophilic contact lenses (V2520, V2521, V2522, V2523) used as a corneal bandage may be considered medically necessary when applied and removed by the physician for the treatment of the following but not limited to conditions:  Bullous keratopathy  Dry eyes  Corneal ulcers and erosion  Keratitis  Corneal edema  Descemetocele  Corneal ectasis  Mooren's ulcer  Anterior corneal dystrophy  Neurotrophic keratoconjunctivitis; OR  Prescribed as a prosthetic lens for the aphakic patient.
Gas impermeable scleral contact lenses (scleral shell or shield) (V2530) when prescribed as a prosthetic device to support surrounding orbital tissue of a shrunken and sightless eye or when prescribed for the treatment of dry eye (failure of lacrimal gland to produce enough tears).
Rigid gas permeable scleral lens (S0515, V2531) may be considered medically necessary for patients who have not responded to topical medications or standard spectacle or contact lens fitting, for the following conditions:  Corneal ectatic disorders (eg, keratoconus, keratoglobus, pellucid marginal degeneration, Terrien's marginal degeneration, Fuchs' superficial marginal keratitis, postsurgical ectasia);  Corneal scarring and/or vascularization;  Irregular corneal astigmatism (eg, after keratoplasty or other corneal surgery);  Ocular surface disease (eg, severe dry eye, persistent epithelial defects, neurotrophic keratopathy, exposure keratopathy, graft vs host disease, sequelae of Stevens Johnson syndrome, mucus membrane pemphigoid, postocular surface tumor excision, postglaucoma filtering surgery) with pain and/or decreased visual acuity. 
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